Abstract
BACKGROUND: Patients with peripheral arterial disease (PAD) have increased mortality compared with patients without PAD. Coronary artery disease (CAD) accounts for almost 75% of deaths in PAD patients. Studies suggest that PAD is underdiagnosed and atherosclerotic risk factors undertreated when compared with CAD.
OBJECTIVE: To determine whether cholesterol guidelines are being met in patients with PAD and to determine whether any independent factors increase the likelihood of reaching goal low-density lipoprotein (LDL).
DESIGN: A retrospective chart review of subjects diagnosed with PAD in 2001 at 2 Veterans Affairs Medical Centers.
MEASUREMENTS: Univariate analysis compares baseline characteristics between those reaching goal and those who do not. Multivariate logistic regression analysis identified predictors of meeting LDL goal among PAD patients.
RESULTS: Of 315 patients, 62% reached goal LDL. Those more likely to reach goal were older, had hypertension, and a history of CAD and stroke. Positive predictors of LDL goal were age and CAD, while smoking was a negative predictor.
CONCLUSION: The majority of veterans with PAD received lipid-lowering medication and achieve goal LDL, but they are more likely to do so if they are older than 70 and have a history of CAD.
Similar content being viewed by others
References
American Cancer Society. Cancer Facts and Figures 2000. Available at: http://www.cancer.org/docroot/stt/content/stt_1x_2000_facts_and_figures.asp. Accessed 2004.
Kempczinski RF, Bernhard VM. Introduction and general considerations [section VIII, management of chronic lower limb ischaemia]. In: Rutherford RB, ed. Vascular Surgery. 3rd ed. Philadelphia, PA: WB Saunders; 1989:643–52.
Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026–49.
Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–6.
Rockson SG, Cooke JP. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Inter Med. 1998;43:253–77.
Orchard TJ, Strandness DE. Assessment of peripheral vascular disease in diabetes—report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association. Circulation. 1993;88:819–28.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–97.
Grundy SM, Cleeman JI, Merz B, Brewer HB. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227–39.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7–22.
Leng GC, Price JF, Jepson RG. Lipid-lowering for Lower Limb Atherosclerosis. The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons; 2004. Available at: http://212.49.218.202/abstract/ab000123.htm.
Mc Dermott MM, Mehta S, Greenland P. Atherosclerotic risk factors are less intensively modified in peripheral arterial disease than in coronary artery disease. J Gen Intern Med. 1997;12:209–15.
Anand SS, Kundi A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol. 1999;15:1259–63.
Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1380–1.
Rehring TF, Sandhoff BG, Stolcpart RS, Merenich JA, Hollis HW Jr. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg. 2005;41:816–22.
Okaa RK, Umoh E, Szuba A, Giacomini JC, Cooke JP. Suboptimal intensity of risk factor modification in PAD. Vasc Med. 2005;10:91–6.
Federman DG, Bravata D, Ranani D, Kirsner RS. Peripheral vascular diseas: are current guidelines being met? Mayo Clin Proc. 2005;80:494–8.
Nass CM, Allen JK, Jermyn RM, et al. Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease. Vasc Med. 2001;6:35–41.
Cote M, Ligetti R, Cutler B, Nelson P. Management of hyperlipidemia in patients with vascular disease. J Vasc Nurs. 2003;21:63–7.
Anand SS, Kundi A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol. 1999;15:1259–63.
Clark AL, Byrne JC, Nasser A, Mc Groarty, Kennedy JA. Cholesterol in peripheral vascular disease-a suitable case for treatment? QJ Med. 1999;92:219–22.
Mc Kenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–28.
Author information
Authors and Affiliations
Corresponding author
Additional information
None of the authors have any conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Banta, M.R., Ma, F., Bravata, D.M. et al. Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease. J Gen Intern Med 21, 711–714 (2006). https://doi.org/10.1111/j.1525-1497.2006.00456.x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2006.00456.x